Sera Prognostics, Inc. Class A SERA 深 沪
等待开盘 05-27 09:30:00 美东时间
2.15
+0.080
+3.86%
华盛通- 最 高2.3699
- 今 开2.27
- 成交量 13.38万股
- 最 低 1.94
- 昨 收 2.07
- 总市值 8419.13万
- 52周最高 4.09
- 市盈率 静 --
- 换手率 0.34%
- 52周最低 1.37
- 委 比 50.94%
- 总股本 3915.87万
- 历史最高 15.50
- 量 比 1.00
- 振 幅 20.77%
- 历史最低 1.10
- 每 手 1
- 风险率 0.62%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Sera Prognostics Q1 EPS $(0.17), Inline, Sales $14.000K Miss $80.000K Estimate
Sera Prognostics (NASDAQ:SERA) reported quarterly losses of $(0.17) per share which met the analyst consensus estimate. This is a 15 percent increase over losses of $(0.20) per share from the same period last year. The
05-07 04:09
Sera Prognostics Q4 EPS $(0.16) Beats $(0.18) Estimate, Sales $10.000K Miss $30.000K Estimate
Sera Prognostics (NASDAQ:SERA) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.18) by 13.51 percent. This is a 36 percent increase over losses of $(0.25) per share from the
03-19 04:08
Earnings Scheduled For March 18, 2026
Companies Reporting Before The Bell • SailPoint (NASDAQ:SAIL) is estimated to r...
03-18 19:11
SERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCE
SALT LAKE CITY, Feb. 17, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnanc...
02-17 21:05
Sera Prognostics Announces Randomized Trial Finds PreTRM Test Improves Outcomes By Identifying Women At Risk For Preterm Birth
Published in the journal PREGNANCY, the PRIME Study demonstrates significant improvements in neonatal outcomes with early risk screening and targeted interventions.SALT LAKE CITY, Jan. 7, 2026 /PRNewswire/ -- A
01-07 21:40
Sera Prognostics Announces Findings Of Prematurity Risk Assessment Combined With Clinical Interventions For Improved Neonatal OutcoMEs Study Accepted For Publication In Peer-Reviewed Journal
The PRIME study, one of the largest studies on preterm birth, has been accepted for publication by a medical journal following abstract presentation earlier this yearSALT LAKE CITY, Nov. 24, 2025 /PRNewswire/ -- Sera
2025-11-24 21:10
Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
2025-11-13 19:11
Sera Prognostics Names Dr. Tiffany Inglis Chief Medical Officer
SALT LAKE CITY, Oct. 1, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
2025-10-01 20:05
